Key result
EchoGraph-FusionNet detects structural heart disease with an AUROC of ~0.83 using multimodal data.
Why the study?
Cardiovascular diseases remain a major global health burden, while echocardiography, despite its diagnostic value, is not always readily accessible. This study developed a multimodal deep learning framework to predict echocardiographic abnormalities and structural heart disease from 12-lead ECGs and clinical variables.
Does EchoGraph-FusionNet accurately predict echocardiographic abnormalities and structural heart disease from 12-lead ECGs and clinical variables?
Does EchoGraph-FusionNet accurately predict echocardiographic abnormalities and structural heart disease from 12-lead ECGs and clinical variables?
EchoGraph-FusionNet demonstrates high discriminative performance in predicting structural heart disease and 11 echocardiographic abnormalities from 12-lead ECGs and clinical variables, offering a potential screening and prioritization tool for echocardiography.
Background/Objectives: Cardiovascular diseases remain a major global health burden, while echocardiography, despite its diagnostic value, is not always readily accessible. This study proposes EchoGraph-FusionNet, a multimodal deep learning framework for predicting echocardiographic abnormalities and structural heart disease (SHD) from 12-lead electrocardiograms (ECGs) and clinical variables. Methods: The framework integrates ECG and clinical representations through cross-modal fusion, followed by a disease-aware mixture-of-experts module and a two-layer adaptive graph attention network that jointly models 11 echocardiographic abnormalities. Five continuous echocardiographic measurements were incorporated as auxiliary regression tasks. Prevalence-aware logit adjustment and asymmetric loss were employed to address class imbalance. Performance was evaluated on the predefined EchoNext training, validation, and held-out test partitions across three independent random seeds. Results: On the held-out test set, EchoGraph-FusionNet achieved a macro AUROC of 0.8066 ± 0.0025 and macro AUPRC of 0.2838 ± 0.0056 across 11 abnormalities. For SHD detection, AUROC and AUPRC reached 0.8345 ± 0.0001 and 0.8039 ± 0.0031, respectively. Conclusions: EchoGraph-FusionNet effectively combines multimodal representations, disease relationships, and multitask learning for ECG-based prediction of echocardiographic abnormalities, supporting its potential as a screening and prioritization approach for structural cardiac assessment.
No takes yet. Share an insight, caveat, or question.
Mirzaoğlu et al. (2026) studied Echocardiographic abnormalities and structural heart disease (SHD). EchoGraph-FusionNet (multimodal deep learning framework using 12-lead ECGs and clinical variables) was evaluated on Prediction of 11 echocardiographic abnormalities and structural heart disease (SHD) detection (Macro AUROC 0.8066 ± 0.0025 (11 abnormalities); AUROC 0.8345 ± 0.0001 (SHD)). EchoGraph-FusionNet predicted 11 echocardiographic abnormalities with a macro AUROC of 0.8066 ± 0.0025 and detected structural heart disease with an AUROC of 0.8345 ± 0.0001.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: